Semen quality in hypogonadal acromegalic patients
- PMID: 31834539
- DOI: 10.1007/s11102-019-01018-x
Semen quality in hypogonadal acromegalic patients
Abstract
Objective: Growth hormone (GH) activity might be implicated in male reproductive function. One previous study has suggested significantly reduced semen quality in untreated acromegalic patients due to both reduced sperm counts and sperm motility.
Design and methods: A retrospective study comprising ten uncontrolled hypogonadal acromegalic patients (median age 29 years) who delivered semen for cryopreservation before initiation of testosterone therapy. Semen variables and hormone concentrations were compared to those of ten non-acromegalic hypogonadal men with pituitary disease (age 31 years) and those of young healthy men.
Results: Acromegalic patients vs. non-acromegalic patients had a higher percentage of progressive motile spermatozoa (62 vs. 47%, p = 0.04). Eight of ten acromegalic patients and 82% of controls had total sperm counts above 39 million and progressive motile spermatozoa above 32% (p = 0.55), corresponding to the WHO 2010 reference levels for expected normal fertility for these variables. Non-acromegalic patients vs. healthy controls had reduced percentage of progressive motile spermatozoa (47 vs. 57%, p = 0.02) and only five of ten patients had semen quality above the WHO reference level, which was significantly lower than observed in healthy controls (p = 0.022). Total sperm counts were similar between both patient groups and controls. There were no differences in reproductive hormone levels between acromegalic patients vs. non-acromegalic patients (p-values between 0.10 and 0.61). Compared to healthy controls both patient groups had severely reduced serum testosterone, calculated free testosterone.
Conclusions: Despite severe hypoandrogenism acromegalic patients had semen quality similar to healthy controls based on determination of the number of progressively motile spermatozoa. By contrast non-acromegalic pituitary patients had reduced sperm motility. Our data do not support reduced semen quality in acromegaly.
Keywords: Acromegaly; Growth hormone; Male reproduction; Semen quality.
Similar articles
-
Evaluation of sex hormone profile and semen parameters in acromegalic male patients.J Endocrinol Invest. 2021 Dec;44(12):2799-2808. doi: 10.1007/s40618-021-01593-6. Epub 2021 May 28. J Endocrinol Invest. 2021. PMID: 34050506
-
Semen quality in patients with pituitary disease and adult-onset hypogonadotropic hypogonadism.Endocr Connect. 2018 Apr;7(4):523-533. doi: 10.1530/EC-18-0061. Epub 2018 Mar 7. Endocr Connect. 2018. PMID: 29514896 Free PMC article.
-
Improved sperm kinematics in semen samples collected after 2 h versus 4-7 days of ejaculation abstinence.Hum Reprod. 2017 Jul 1;32(7):1364-1372. doi: 10.1093/humrep/dex101. Hum Reprod. 2017. PMID: 28531319
-
Compensated reduction in Leydig cell function is associated with lower semen quality variables: a study of 8182 European young men.Hum Reprod. 2016 May;31(5):947-57. doi: 10.1093/humrep/dew021. Epub 2016 Mar 2. Hum Reprod. 2016. PMID: 26936886
-
Testicular function in a birth cohort of young men.Hum Reprod. 2015 Dec;30(12):2713-24. doi: 10.1093/humrep/dev244. Epub 2015 Sep 25. Hum Reprod. 2015. PMID: 26409015
Cited by
-
Approach of Acromegaly during Pregnancy.Diagnostics (Basel). 2022 Nov 2;12(11):2669. doi: 10.3390/diagnostics12112669. Diagnostics (Basel). 2022. PMID: 36359512 Free PMC article. Review.
-
Acromegaly and male sexual health.Rev Endocr Metab Disord. 2022 Jun;23(3):671-678. doi: 10.1007/s11154-022-09721-0. Epub 2022 Apr 1. Rev Endocr Metab Disord. 2022. PMID: 35364803 Free PMC article. Review.
-
Effects of Growth Hormone on Adult Human Gonads: Action on Reproduction and Sexual Function.Int J Endocrinol. 2023 Apr 7;2023:7492696. doi: 10.1155/2023/7492696. eCollection 2023. Int J Endocrinol. 2023. PMID: 37064267 Free PMC article. Review.
-
Evaluation of sex hormone profile and semen parameters in acromegalic male patients.J Endocrinol Invest. 2021 Dec;44(12):2799-2808. doi: 10.1007/s40618-021-01593-6. Epub 2021 May 28. J Endocrinol Invest. 2021. PMID: 34050506
-
Every Third Male Patient with Acromegaly Recovers from Hypogonadism after Neurosurgical Treatment.J Clin Med. 2024 Sep 18;13(18):5526. doi: 10.3390/jcm13185526. J Clin Med. 2024. PMID: 39337013 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources